Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data... Show more
Marchex is a conversation-intelligence and AI-enabled marketing-analytics company that helps enterprises in verticals such as automotive, home services, and healthcare turn phone calls, texts, and conversations into actionable data. Its future outlook hinges on a deliberate repositioning: moving beyond selling standalone analytics toward bundling AI-powered tools that not only surface insights but also automate actions and verify outcomes, such as booked appointments and qualified sales conversations.
This bundling strategy is central to the company's market positioning. Because its largest customers already rely on Marchex for conversational data, management sees an opportunity to meaningfully increase revenue per customer by layering on outcome-based products. Management has indicated that certain bundles could roughly double revenue per customer, which would materially expand the company's total addressable market without requiring a large influx of new logos. However, the competitive landscape remains challenging: Marchex operates alongside larger marketing-technology and customer-engagement platforms with far greater scale and resources. Its structural risk is that a concentrated customer base and a comparatively small research-and-development budget could limit its ability to keep pace with well-funded AI competitors.
The single most consequential upcoming catalyst is the completion of the Archenia acquisition, announced in May 2026 and expected to close in July 2026, subject to approval by Marchex's disinterested stockholders. Archenia specializes in real-time consumer-intent detection and AI-verified, outcome-based customer acquisition, capabilities management believes will create a vertically focused platform spanning insights, actions, and outcomes. On a combined basis, Marchex has guided to a revenue run rate of approximately $15 million per quarter, or $60 million annualized, with growth in the 15% to 20% range during 2026 and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) margins trending to 10% or more.
Earnings releases remain important sentiment drivers. For the third quarter of 2026, the company guided to sequential revenue growth and potential acceleration, with standalone adjusted EBITDA of about $2 million or more, or roughly $2.5 million or more if the Archenia transaction closes, implying an annualized run rate of $10 million or more. Management has also pointed to a "Rule of 30 to 40" goal, a metric combining annual revenue growth with adjusted EBITDA margins, as a medium-term profitability benchmark.
On the analyst front, coverage is limited but currently constructive. Northland Securities analyst Michael Latimore has maintained a Buy rating with a $4.00 price target, and the consensus recommendation on MCHX is a Moderate Buy with an average price target of $4.00. Because coverage is thin, any new initiation, upgrade, downgrade, or target revision could have an outsized influence on investor sentiment. A separate $3 million share-buyback authorization signals management's view that the stock may not fully reflect the company's value.
Marchex's trajectory is tightly linked to the broader adoption of generative AI and conversational analytics across enterprise marketing. As businesses seek measurable return on investment from their customer-acquisition budgets, demand for AI-verified outcomes rather than raw impressions or clicks could support Marchex's repositioning. Technology-adoption trends in verticals such as automotive and home services, where phone conversations still drive high-intent purchases, are particularly relevant.
At the same time, Marchex is macro-sensitive in ways that cut both ways. Its customer base includes discretionary, advertising-driven sectors that can pull back on marketing spend when interest rates remain elevated or consumer demand softens. Inflation and cost-consciousness could pressure customer budgets, while higher financing costs may weigh on the same small-cap, currently unprofitable companies that investors typically reward only for demonstrated margin expansion. The regulatory climate around AI, data privacy, and call-recording consent also bears watching, since conversation-based products depend on compliant data collection and usage.
For traders seeking a data-driven read on where MCHX might head next, Tickeron's Trend Prediction Engine offers an AI-powered forecasting tool designed to help identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. The engine is built to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. Its interface includes searchable prediction categories, historical context, and alert-oriented functionality so that users can monitor signals as conditions evolve. Exploring these AI-driven trend signals alongside Marchex's fundamental catalysts can give investors a more complete forward-looking picture.
Looking into 2026 and beyond, Marchex's long-term story rests on a few structural themes. First is market-expansion opportunity: if the Archenia integration succeeds, the combined company's ability to cross-sell and bundle solutions across a larger installed base could unlock what management describes as a $100 million revenue opportunity over time. Second is cost-structure evolution, as platform migration and operational efficiencies are expected to lift margins even before a full revenue reacceleration takes hold.
Margin sustainability will be a key test. Management has guided to adjusted EBITDA margins of 10% or more for 2026, but sustaining that improvement depends on disciplined operating-expense control and on converting early paid pilots into recurring, higher-value subscriptions. Technology transitions also carry execution risk: moving customers from legacy platforms to the newer Marchex Engage platform has already created some revenue dilution, and any friction in that migration could delay the growth inflection.
Competitive threats from larger AI and marketing-technology vendors remain the most significant structural risk, alongside the concentration of revenue in a small number of customers. Capital-allocation priorities, including the $3 million buyback and the Archenia transaction, will signal how aggressively management is willing to consolidate its position. With consensus estimates pointing toward a return to profitability within a few years and a single covering analyst holding a $4.00 target, sentiment is likely to remain highly sensitive to execution milestones rather than to broad market moves.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ALIL | 30.07 | 0.37 | +1.24% |
| Argent Focused Small Cap ETF (ALIL) | |||
| UMMA | 35.86 | 0.31 | +0.86% |
| Wahed Dow Jones Islamic World ETF (UMMA) | |||
| PTBD | 18.34 | 0.01 | +0.05% |
| Pacer Trendpilot US Bond ETF (PTBD) | |||
| HULL | 27.20 | N/A | N/A |
| Corgi ETF Trust I Corgi Shipping & Global Logistics ETF (HULL) | |||
| KXI | 70.59 | -0.41 | -0.58% |
| iShares Global Consumer Staples ETF (KXI) | |||
A.I.dvisor tells us that MCHX and EVC have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MCHX and EVC's prices will move in lockstep.
| Ticker / NAME | Correlation To MCHX | 1D Price Change % | ||
|---|---|---|---|---|
| MCHX | 100% | -0.78% | ||
| EVC - MCHX | 33% Poorly correlated | -0.32% | ||
| STGW - MCHX | 20% Poorly correlated | -0.22% | ||
| BOC - MCHX | 20% Poorly correlated | -0.48% | ||
| NCMI - MCHX | 20% Poorly correlated | -3.41% | ||
| ABLV - MCHX | 20% Poorly correlated | +4.46% | ||
More | ||||
a provider of advertising and marketing services
Industry AdvertisingMarketingServices
The Moving Average Convergence Divergence (MACD) for MCHX turned positive on September 29, 2026. Looking at past instances where MCHX's MACD turned positive, the stock continued to rise in 41 of 46 cases over the following month. The odds of a continued upward trend are 89%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MCHX's RSI Indicator exited the oversold zone, 28 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +7.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where MCHX advanced for three days, in 164 of 224 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
MCHX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MCHX as a result. In 82 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The 50-day moving average for MCHX moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCHX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.940) is normal, around the industry mean (-1.137). P/E Ratio (-9.769) is within average values for comparable stocks, (18.204). Projected Growth (PEG Ratio) (0.780) is also within normal values, averaging (1.501). MCHX's Dividend Yield (1.575) is considerably higher than the industry average of (0.083). P/S Ratio (1.439) is also within normal values, averaging (1.860).
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. MCHX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MCHX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.